MMR Vaccine’s Poison Pill: Mumps After Puberty, Reduced Testosterone and Sperm Counts

1 Comment

This article represents Part I of a two-part series on mumps. Part II will delve further into the mumps vaccine’s spillover effects on fertility.

By Robert F. Kennedy, Jr., Chairman of the Board, Children’s Health Defense

Across the country, frenzied legislators are responding to the pharmaceutical industry’s orchestrated fear campaign around measles by seeking to impose further mandating of Merck’s measles, mumps and rubella (MMR) vaccine. Although ongoing mumps outbreaks involving thousands of at-risk adolescents and young adults completely dwarf the number of measles cases, no one is covering the mumps story—because it will expose the fact that Merck has been in court for over eight years due to scientists blowing the whistle on Merck’s fabrication and falsification of the effectiveness of the mumps component of its MMR vaccine. Instead of punishing Merck for its chicanery, legislatures are rewarding the company by making it impossible to refuse Merck’s profitable vaccine, subjecting a generation of American children to the risk of serious complications from mumps infection at an age that nature never intended.

When younger children experience mumps, the virus is relatively harmless; infected children often exhibit no symptoms. When mumps strikes adolescents or adults, on the other hand, the infection can cause far more serious adverse effects, including inflammation of various organs (brain, pancreas, ovaries and testicles)—as well as damage to male fertility.

Inflammation of one or both testicles (a condition called orchitis) occurs in approximately one in three post-pubertal men who get mumps and can contribute to sperm defects and subfertility as well as impairing the function of cells that produce testosterone. An estimated 30% to 87% of men with bilateral orchitis induced by mumps experience full-blown infertility—a major cause for concern given the significant declines in male fertility observed over the past several decades. Thus, it appears that Merck’s vaccine, instead of protecting children, not only delays onset of disease to later age cohorts but has the potential to cause serious and permanent injury.

Merck and mumps vaccines

Let’s look at a quick history of mumps and MMR vaccination in the United States. The Food and Drug Administration (FDA) licensed Merck’s initial mumps-only vaccine in 1967. In 1971, Merck introduced its first combination MMR vaccine, followed by the MMR-II vaccine in 1978 (which repurposed the rubella component) and the MMR-plus-varicella (MMRV) ProQuad vaccine in 2005. Since the initial 1967 vaccine, Merck has enjoyed a unique monopoly position in the U.S. market for mumps and MMR vaccines, with combined sales of MMR-II and ProQuad bringing in over $720 million in 2014 alone. Merck consistently places in the top five pharmaceutical companies globally, and the market valued its stocks at a seven-year high as of late 2018. More


Children’s Health Defense: Stripping Away Rights


February 28, 2019

The Reality of Vaccine Injury: A Much Needed Lesson for Carly Weeks

“My bill deals with the occurrences and documentation of severe side-effects which can result from the vaccination of infants and children. Some members may not be aware that the routine vaccination called DPT, diphtheria, pertussis and tetanus, given to almost every one of our children, can lead to convulsions, brain damage and even death.”

“Vaccines are not safe and effective for everyone. This cannot be a one-size-fits-all. Not everyone had the same risk factors. This is not a 1-in-a-million type issue; there can be 10 to 15% of people who are susceptible. This is a liability-free product that is being mandated on children with genetic susceptibility, and the injuries are serious, include death and encephalopathy. If you eliminate these exemptions, you are making a large minority susceptible to very serious risks, including death.” — Dr. Toni Bark

%d bloggers like this: